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Infection of quiescent cells with the DNA tumor virus simian virus 40 induces expression of the cellular
thymidine kinase (TK) gene a minimum of 10- to 20-fold, and this induction depends upon the viral protein
large T antigen (T-Ag). To define both human TK promoter elements and T-Ag functional domains required
for transcriptional induction, we have established a system in which stable Rat-1 transfectants harboring TK
promoter-luciferase hybrid genes are infected with recombinant adenoviruses expressing either wild-type or
mutant forms of T-Ag and luciferase expression is measured as an indicator of promoter activity. The results
show that (i) a 135-bp TK promoter fragment is activated 10- to 15-fold by viral infection; (ii) this activation
is the result of both T-Ag-dependent and -independent mechanisms; (iii) the T-Ag pRb family-binding domain,
but not the p53-binding, helicase, or ATPase domain, is required for activation; and (iv) activation is severely
diminished with a TK promoter fragment in which E2F-like-binding sites have been removed. These data
demonstrate a requirement for both an E2F-related factor and a pRb family member in activation of the TK
promoter by T-Ag. This contrasts with the promiscuous activation of many cellular and viral genes by T-Ag,
which is independent of its ability to bind pRb.
viral and cellular promoters. Analyses of these promoters have
revealed that the only requirements for activation by T-Ag are
either a TATA or initiator element and an upstream factorbinding site of variable nature. These findings suggest that the
mechanism of activation might be via direct interaction of
T-Ag with the basal transcription apparatus, and they are consistent with its documented ability to bind factors such as TBP
and TEF-1 (2, 23, 28). By using a truncated form of T-Ag, the
ability to trans activate simple promoters in transient assays
was localized to the N-terminal 138 amino acids of the protein
(54). An analysis of mutations within this region identified
several, including inA2803 and dl2831 (see Fig. 5), which encode proteins that were defective in trans-activation assays.
The K1 mutation, which eliminates pRb binding (12, 18, 30),
did not affect the activity, indicating that pRb binding is not
required for the general trans-activation function of T-Ag.
Several lines of evidence suggest that the specific activation
of cellular genes at G1/S phase by T-Ag might occur by a
mechanism different from the one identified in the transientcotransfection assays described above. First, although T-Ag
activates many different promoters in transient assays, only a
small subset of cellular genes are activated during viral infection. Second, the pRb-binding function of T-Ag seems likely to
be involved in the induction of cellular genes involved in DNA
replication. pRb, and the related proteins p107 and p130, act
by binding to members of the E2F family of transcription
factors and inhibiting their trans-activation functions (7, 9, 19,
25). Viral proteins such as T-Ag bind to pRb family proteins,
thereby releasing E2F, which then activates target genes (8).
Potential E2F-binding sites have been identified in the promoters of many S-phase-regulated genes, including the TK
gene, and in some cases have been shown to be critical for
regulation in serum-stimulated cells (37, 46). In addition, an
E2F-binding site within the murine TK promoter has been

When quiescent, serum-starved cells are infected with the
DNA tumor virus simian virus 40 (SV40), they reenter the cell
cycle and progress to S phase (47). During this mitogenic
stimulation, a number of cellular genes involved in DNA synthesis, including the thymidine kinase (TK) gene, are induced
(34). Both the induction of cellular DNA synthesis and TK
gene expression depend upon the viral protein large T antigen
(T-Ag) (43). T-Ag is a multifunctional protein involved in the
initiation of viral DNA replication and the regulation of viral
transcription. It is also required for the immortalization and
transformation of cells and has been shown to be a potent trans
activator of a number of viral and cellular promoters (1, 20, 31,
52, 54, 55). The domains of T-Ag required for many of these
activities have been identified. They include DNA-binding,
ATPase, and helicase domains that are required for SV40
replication (6, 11, 40, 50) and several domains which interact
with cellular proteins, such as DNA polymerase a (13, 14), the
pRb family of proteins (12, 16), p53 (36), and TEF-1 and TBP
(2, 23, 28). The alteration of host cell regulatory pathways by
T-Ag is generally believed to be due to its ability to interact
with these cellular proteins (10).
Although a great deal is known about the activities of T-Ag,
it is not clear which ones are responsible for the induction of
genes such as TK at the onset of S phase. Most studies on
transcriptional activation by T-Ag have utilized transient-cotransfection assays (20, 31, 54), and, under these conditions, it
has been shown that T-Ag is a promiscuous activator of many
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found to be a target for activation by polyomavirus large T-Ag
(41, 42). It therefore seems possible that SV40 T-Ag utilizes
multiple mechanisms to activate transcription of target genes,
some that are specific to S-phase-regulated genes and some
that are more general and act on a variety of promoters. The
general mechanisms may function only when the target gene is
episomal. This is suggested by the example of the Rous sarcoma virus long terminal repeat, which is activated by T-Ag in
transient transfections in CV1 cells (54) but not during viral
infection when it is stably integrated into the CV1 cell chromosome (44).
In this study, we have investigated the mechanism by which
SV40 T-Ag activates the human TK promoter, a natural target
of T-Ag during viral infection. Previous studies showed that
TK mRNA is highly induced during SV40 infection (49) and
that at least some of this induction occurs at the level of
transcription (44). By studying the expression of hybrid genes,
we and others demonstrated that a human TK promoter fragment containing 135 bp upstream and 30 bp downstream of the
transcriptional start site was sufficient to confer regulation to
linked heterologous genes in both SV40-infected and serumstimulated cells. The cis-acting elements required for regulation in serum-stimulated cells were initially mapped to a region
between bp 2135 and 267 relative to the transcriptional start
site (32, 45), and it was later shown that replacement of sequences between bp 288 and 2113 with nonhomologous sequences abolished serum regulation (33). The sequences contained within this 25-bp segment include several potential E2Fbinding sites, implicating E2F or a related factor in serummediated regulation. E2F has been shown to activate human
TK gene expression in transient-transfection assays (27), further indicating its potential importance. Gel shift mobility
studies with the 25-bp fragment mentioned above identified
G1/S-phase-specific formation of a complex containing both
cyclin A and p107 (37), proteins which have been shown to
interact with E2F (5). In addition, E2F-containing protein
complexes have been reported to bind to the mouse TK promoter (15). However, oligomers containing a single consensus
E2F site were ineffective at competing with the human TK
promoter fragment for complex formation, and anti-E2F antiserum was inefficient at affecting complex formation (37),
thereby putting in doubt the role of E2F in human TK promoter regulation.
In this study, we analyzed both human TK promoter elements and SV40 T-Ag protein domains required for activation.
We have developed a system in which Rat-1 cell lines stably
transfected with TK promoter-luciferase (TK-Luc) hybrid
genes are infected with recombinant adenoviruses expressing
either wild-type or mutant forms of SV40 T-Ag. Our results
indicate that both the pRb family-binding domain of T-Ag and
the putative E2F-binding sites within the TK promoter are
critical, suggesting an activation mechanism involving associations between T-Ag, a pRb family member, and an E2F-related
protein.
MATERIALS AND METHODS
Cell culture. Rat-1 cells were cultured at 378C in Dulbecco’s modified Eagle’s
medium (DME) supplemented with 10% calf serum (HyClone Laboratories,
Logan, Utah). Stably transfected cells containing hygromycin resistance (Hgmr)
genes were maintained in medium containing 50 mg of hygromycin B (CalBiochem-Novabiochem Corporation, La Jolla, Calif.) per ml. Cells were grown in
medium without hygromycin B for all virus infection experiments. Human 293
cells (22) were cultured in DME containing 5% calf serum.
Plasmid constructions. PGL2-Basic, a promoterless luciferase vector, was
obtained from Promega Corporation (Madison, Wis.). pY3 (3) is a plasmid
conferring Hgmr. 135-Luc consists of TK promoter sequences between bp 2135
and 130, relative to the transcriptional start site, subcloned upstream of the
firefly luciferase gene (Luc) in PGL2-Basic. HTK-Luc contains 131 bp of the
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FIG. 1. Structure of human TK-Luc hybrid genes. Open bars, human TK
promoter region; stippled bar, herpes simplex virus TK promoter sequences;
striped bars, luciferase reporter gene; solid bars, prokaryotic vector sequences.
Putative regulatory elements within the human TK promoter region are indicated. Numbers refer to sequence locations within the respective TK promoter.
Sequences mutated in 135(E2F)-Luc are indicated; the wild-type sequence is
shown in uppercase, and the nonhomologous substitution sequence is shown
below it in lowercase.

herpes simplex virus TK promoter (bp 275 to 156) (39) linked to Luc.
135(E2F)-Luc contains TK promoter sequences between bp 2135 and 130, with
a substitution of nonhomologous sequences for promoter sequences between bp
298 and 2113, as shown in Fig. 1. This mutation, which was generated via
oligonucleotide-mediated mutagenesis in M13 (35), is identical to one which
abolishes regulation during serum stimulation (33). The presence of the mutation was confirmed by DNA sequencing, and the mutated promoter fragment
was excised from M13 and subcloned upstream of Luc in the PGL2-Basic vector.
T-Ag-coding sequences were derived from the vector wtTag/pACSE, which
was a gift of Y. Gluzman. This plasmid contains a wild-type SV40 T-Ag gene
flanked by parts of the E1A and E1B regions of the adenovirus genome. Mutants
of T-Ag (inA2803, dl2831, K1, inA2809, inA2811, and inA2827) were transferred
into pACSE as BamHI-KpnI fragments. These mutants include point mutations
and small, in frame insertions or deletions and are described elsewhere (30, 53).
(Their locations within T-Ag are shown in Fig. 5.)
Construction and growth of recombinant viruses. The recombinant adenoviruses used in these studies contain wild-type or mutant T-Ag-coding sequences,
under the control of the SV40 promoter, inserted in place of the E1A and E1B
genes in adenovirus dl309 (Ad T/dl309) (29). To construct these recombinant
adenoviruses, adenovirus dl309 (a gift of T. Shenk) was propagated on 293 cells,
and viral DNA was prepared. This DNA was digested with XbaI plus ClaI, which
gave rise to one fragment encompassing 96% of the genome plus two small (2%)
fragments from the left end of the genome. The 96% fragment was isolated by
gel filtration on a Sephacryl S-1000 column (1.5 by 80 cm) (Pharmacia) in a buffer
containing 109 mM Tris-Cl (pH 7.5), 2 mM EDTA, and 100 mM NaCl. The
desired fragment eluted in the void volume and was well separated from the two
2% fragments.
To introduce T-Ag-coding sequences into the Ad T/dl309 vector, 293 cells
were seeded subconfluently on 60-mm-diameter dishes and cotransfected the
following day with 2 mg of a pACSE plasmid containing wild-type or mutant
T-Ag-coding sequences, 2 mg of the 96% adenovirus dl309 fragment, and 14 mg
of salmon sperm DNA per plate. In each case, the plasmid DNA was linearized
by digestion with SalI before transfection. Six to nine hours after the addition of
DNA, the medium was removed, cells were washed twice with Tris-buffered
saline, and 4 ml of overlay (DME containing 4% fetal bovine serum and 0.4%
agarose) was added. The plates were incubated for 8 to 10 days (with feeding
every 3 days), at the end of which time individual plaques were isolated. The
recombinant viruses were plaque purified twice before amplification for use in
experiments. The identities of the recombinant viruses were verified by isolating
viral DNAs and analyzing their restriction endonuclease digestion patterns and
by staining infected cells with a panel of anti-T-Ag monoclonal antibodies known
to recognize distinct regions of the protein and to discriminate among various
mutant T-Ags (9a).
Large-scale viral stocks were prepared by infecting monolayers of 293 cells
with single-plaque-derived virus resuspended in 5 ml of DME plus 2% calf
serum. Cytopathic effects were observed 2 to 3 days following infection, at which
point cells were scraped from the plate, lysed by two rounds of freezing and
thawing, and then centrifuged at 2,000 rpm for 30 min in an SS34 rotor at 48C to
pellet cell debris. The supernatant was passed through a 0.45-mm-pore-size filter
and stored at 2708C. Viral titers were determined by plaque assays on 293 cells
and were generally between 5 3 108 and 1 3 109 PFU/ml. The absence of
wild-type adenovirus was verified by the inability of the stocks to form plaques on
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HeLa cells. Mock virus is a 293 cell lysate prepared by a procedure identical to
that used for generating viral stocks except that the cells received 5 ml of DME
plus 2% calf serum without virus.
To prepare UV-irradiated virus, 2.5 ml of virus was transferred to a 60-mmdiameter dish, placed uncovered in a UV Stratalinker 1800 cross-linker (Stratagene, La Jolla, Calif.), and irradiated with six 2-min pulses of 1,200 mJ of UV
light. The virus was irradiated just prior to use and then placed on ice. To
minimize light exposure and prevent light-induced repair mechanisms, irradiated
stocks were kept covered with aluminum foil and infections were performed in
the absence of fluorescent lights.
Ad T/dl309 infections of rat cells. To synchronize cultures in G0, cells were
plated at a density of 105 cells per 60-mm-diameter plate, grown to confluence,
and then serum starved for 24 h in medium containing 0.5% calf serum. For
infection, the medium was removed at the end of the serum starvation and saved.
Virus was diluted in DME plus 0.5% calf serum, and cells were infected at a
multiplicity of infection (MOI) of 200 in a total volume of 0.6 ml. Infections were
done for 1.5 h at 378C. Following infection, the original low-serum medium was
returned to the cultures, which were then incubated at 378C until harvest.
DNA transfections. Stable transfections into Rat-1 cells were performed by
using Lipofectin reagent (BRL Life Technologies, Gaithersburg, Md.) according
to the procedure supplied by the manufacturer. Each transfection (60-mmdiameter dish) contained 8 mg of TK-Luc DNA and 2 mg of pY3 DNA. Approximately 48 h after transfection, cells were split into medium containing 200 mg of
hygromycin B per ml. When resistant colonies emerged, several colonies were
picked and propagated as clonal cell lines. After the initial selection, transfected
cells were maintained in medium containing 50 mg of hygromycin B per ml.
Preparation of whole-cell extracts and luciferase assays. To prepare extracts,
plates were rinsed with phosphate-buffered saline (PBS), and cells were scraped
into an Eppendorf tube in 1.5 ml of PBS. Cells were pelleted and then resuspended in 100 ml of lysis buffer (125 mM Tris [pH 7.8] with H3PO4, 10 mM
CDTA (1,2-diaminocyclohexane-N,N,N9,N9,-tetraacetic acid), 10 mM dithiothreitol, 50% glycerol, and 5% Triton X-100) and allowed to lyse for 15 min at room
temperature. Extracts were centrifuged for 1 min at room temperature to pellet
cell debris, and supernatants were stored at 2708C until assayed.
Luciferase assays were done according to the protocol supplied by Promega
Corporation. Twenty microliters of extract was placed in a polypropylene tube (8
by 50 mm) (Turner Designs, Sunnyvale, Calif.) in a Turner TD-20E luminometer
(Turner Designs). Substrate solution (100 ml) (270 mM Coenzyme A, 470 mM
luciferin, and 530 mM ATP) was added, and activity was measured during a 1-min
reaction. The luciferase activity (in light units) in each sample was normalized to
the total protein content to calculate the specific activity of the sample (light
units per microgram of protein). Fold inductions in luciferase expression were
determined by dividing the specific activity at 72 h by the corresponding activity
at 0 h. D-luciferin (sodium salt), acetyl coenzyme A, MgCO3, and Tricine were
obtained from Sigma (St. Louis, Mo.).
TK enzyme assays. Assays for endogenous TK enzyme activity were performed
as previously described (49), except that the extracts used were those prepared
for luciferase assays. TK activities (counts per minute) were normalized to total
protein content.
Protein quantitation, SDS-polyacrylamide gel electrophoresis, and Western
blotting (immunoblotting). The amount of protein in cell extracts was determined by using the Bio-Rad protein assay system (Bio-Rad, Richmond, Calif.),
which is based upon the method of Bradford (4). To verify the presence of SV40
T-Ag, 25 to 30 mg of protein from whole-cell extracts were electrophoresed on
sodium dodecyl sulfate (SDS)-polyacrylamide gels, transferred to polyvinylidene
difluoride polyscreen membranes (Dupont-NEN, Boston, Mass.), and probed
with the T-Ag-specific monoclonal antibody L19 (24) or Pab416 (a gift of E.
Harlow). Bands were visualized by using the Lumiglow chemiluminescent reagents (Kirkegaard & Perry, Gaithersburg, Md.).

RESULTS
Generation of stable TK-Luc cell lines and use of T-Agencoding viruses. The TK-Luc constructs used in these studies
are diagramed in Fig. 1 and are described in detail in Materials
and Methods. These hybrid genes were stably transfected,
along with a plasmid conferring Hgmr, into Rat-1 cells. In
previous experiments, we have shown that transfected human
TK minigenes are regulated in these cells (45). Stable transfections were performed because T-Ag is able to activate most
promoters tested in transient assays (1, 54), while only a very
limited subset of chromosomal genes are activated following
SV40 infection. We therefore concluded that studying the activation of stably integrated genes would be the most appropriate way in which to identify mechanisms used to induce
cellular genes following infection with SV40.
Following transfection, Hgmr colonies were selected, individual colonies were expanded into clonal cell lines, and cycling
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populations of each clonal cell line were tested for luciferase
expression. Those colonies expressing no luciferase activity
were discarded, as were those expressing extremely high levels
of activity (i.e., thousands of light units). Colonies chosen for
analysis contained moderate levels of luciferase activity in cycling cells. All experiments were conducted with four to six
independent colonies for each construct tested.
Recombinant adenoviruses (Ad T/dl309) containing T-Agcoding sequences in place of the adenovirus E1A and E1B
genes were used to introduce mutant and wild-type T-Ags into
cells. These viruses were used because several of the T-Ag
mutants to be studied could not be propagated as SV40, since
they are replication defective and also show trans-dominant
interference with wild-type T-Ag (53). The recombinant adenoviruses are replication defective in the absence of E1A and
E1B but can be propagated on 293 cells, which constitutively
express these proteins. Infection was chosen as the best
method for introducing T-Ag into cells because it is a highly
efficient process and more closely parallels the natural sequence of events occurring upon infection of a host cell by
SV40 than does transfection.
Preliminary experiments were conducted to establish conditions for the efficient infection of rat cells containing stably
integrated copies of 135-Luc with Ad T/dl309. Cells were serum starved and infected with virus as described in Materials
and Methods. Infections were done at MOIs of 0, 10, 25, 50,
100, and 200, and cells were harvested for both luciferase and
endogenous TK enzyme assays at various times from 0 to 72 h
postinfection. In addition, infected cells were processed for
detection of T-Ag by immunofluorescence at each of the time
points. The number of cells expressing T-Ag increased with
both increasing MOI and time of incubation, with 100% of the
cells staining positive for T-Ag by 72 h postinfection at an MOI
of 200. Likewise, expression of both the transfected luciferase
gene and the endogenous rat TK gene increased throughout
the time course, with the highest levels of induction being seen
at 72 h postinfection at an MOI of 200 (data not shown).
Subsequent experiments were therefore carried out by infecting cells for 72 h at an MOI of 200.
Induction of TK-Luc hybrid gene constructs in cells infected
with wild-type Ad T/dl309. Clonal cell lines containing stably
integrated 135-Luc were synchronized in G0 and infected with
the Ad T/dl309 recombinant adenovirus, and luciferase induction was determined as described in Materials and Methods.
To verify that any induction detected was due to viral gene
expression, cells were also infected in parallel with UV-irradiated virus. Figure 2 shows the average luciferase induction for
four clonal cell lines, determined in multiple experiments using
several different viral stocks. Induction levels ranged from approximately 10- to 15-fold, indicating that the 135-bp human
TK promoter fragment was highly induced this system. For
each clonal line, luciferase induction was reduced approximately 70% by UV irradiation.
As shown in a representative immunoblot in Fig. 3A, no
T-Ag was detected in extracts from cells infected with UVirradiated virus, indicating that UV irradiation effectively abolished viral gene expression. Figure 3B and C compare the
patterns of luciferase and endogenous TK enzyme inductions
in the same experiment shown in Fig. 3A and demonstrate that
UV irradiation of the virus reduced induction of the endogenous TK gene to a similar extent as for the transfected 135-Luc
gene. These results indicate that activation of the TK promoter
is largely dependent on the expression of viral early genes.
They also suggest the existence of a T-Ag-independent mechanism of induction, since UV-irradiated virus preparations ac-
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FIG. 2. Induction of luciferase in 135-Luc cells infected with untreated (UT)
or UV-irradiated (UV) wild-type virus. Results for four independent clonal cell
lines are shown. Extracts were prepared for luciferase analysis at both the time
of infection (0 h) and 72 h after infection. Fold luciferase induction indicates the
increase in luciferase expression at 72 h relative to expression at 0 h and is
calculated as described in Materials and Methods. 72 un refers to uninfected cells
maintained in low-serum medium throughout the infection. For each sample, the
number of experiments (n) is as follows. Colony 1: UT, n 5 10; UV, n 5 9; 72
un, n 5 9. Colony 3: UT, n 5 10; UV, n 5 10; 72 un, n 5 9. Colony 4: UT, n 5
5; UV, n 5 5; 72 un, n 5 5. Colony 6: UT, n 5 5; UV, n 5 5; 72 un, n 5 4. Error
bars reflect the standard error of the mean.

tivated 135-Luc approximately twofold compared with uninfected controls.
To establish that the T-Ag-mediated induction described
above was specific to the human TK promoter, clonal cell lines
containing the control plasmid HTK-Luc (Fig. 1) were infected
with Ad T/dl309 and assayed for luciferase expression at 0 and
72 h. Since the herpes simplex virus TK promoter is not proliferation regulated, it should not respond to T-Ag in these
assays. Figure 4A shows the average levels of luciferase induction for four independent cell lines containing HTK-Luc. Expression in three of the four clonal lines was induced only twoto threefold upon infection with the untreated Ad T/dl309
virus. This level of activation is consistent with the low level of
T-Ag-independent induction detected as described above. The
induction of HTK-Luc colony 9 was more substantial, approximately sixfold.
Induction levels for three HTK-Luc colonies infected with
unirradiated and UV-irradiated virus are shown in Fig. 4B.
Luciferase induction levels following infection with the UVirradiated virus were similar to those attained upon infection
with untreated virus, indicating that the two- to threefold induction of HTK-Luc (sixfold induction for colony 9) was indeed the result of T-Ag-independent events.
Induction of 135-Luc in cells infected with mutant Ad T/dl309
viruses. The T-Ag protein, diagrammed in Fig. 5, contains a
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number of functional domains, several of which are involved
in binding to cellular proteins. To assess the requirement for
these functional domains in TK promoter induction, a series of
Ad T/dl309 viruses expressing mutant T-Ag proteins were examined. As shown in Fig. 5, three of the mutations (inA2809,
inA2811, and inA2827) are located within the overlapping Cterminal ATPase, helicase, and p53-binding domains of the
protein. T-Ags harboring the inA2809 and inA2811 mutations
are defective in the ability to bind p53, while inA2827 T-Ag
binds p53 with wild-type affinity (52, 55). These C-terminal
mutants previously showed wild-type levels of activation of
simple promoters in transient-transfection assays (54). The
remaining three mutations (inA2803, dlA2831, and K1) localize to N-terminal domains utilized for interaction with cellular
factors. T-Ags containing either the inA2803 or dlA2831 mutation were defective for trans activation of some promoters in
transient assays (54), while T-Ag containing the K1 mutation,
which is defective for binding to pRb family members (12, 18),
retained wild-type activity in these assays (54).
Serum-starved Rat-1 cells containing 135-Luc were infected
with the mutant viruses described above, and luciferase induction was measured. The C-terminal mutations, inA2809,
inA2811, and inA2827, had little or no effect on the activation
of 135-Luc. Induction levels with inA2827 were consistently at
or above the levels attained with wild-type virus. Induction
levels with the p53-binding mutants inA2809 and inA2811 were
also at or near wild-type levels in most experiments but were
low in some experiments. We noted, however, that the level of
T-Ag in infected cells was also sometimes low with these viruses. Figure 6 shows the results of one experiment in which
T-Ag levels were near wild type and demonstrates that luciferase induction levels were also near or above wild type for
both inA2809 and inA2811. The inA2827 virus in this experiment showed greater-than-wild-type levels of luciferase induction, as described above. Therefore, the C-terminal ATPase,
helicase, and p53-binding activities are not required for T-Agmediated activation of the human TK promoter.
In contrast to the results with the C-terminal mutants, luciferase induction levels were consistently decreased to near
background (UV-irradiated) levels in cells infected with viruses expressing the N-terminally mutated T-Ags inA2803,
dl2831, and K1. Western blots of extracts from cells infected
with viruses containing the inA2803 and dl2831 mutations,
however, showed very low-level or no detectable T-Ag. This
was true in a number of experiments and with several antibodies, including a polyclonal antiserum (data not shown). It therefore appears that the T-Ags encoded by these two mutants are
very unstable in rat cells, and the role of these mutations in TK
promoter activation could not be evaluated. In contrast to
in2803 and dl2831, the K1 mutation encoded a stable T-Ag.
Figure 7 compares the K1 mutant with the wild type in several
independent experiments and shows that although T-Ag levels
were equivalent with the two viruses, luciferase induction levels
were reduced 50 to 70% with the K1 virus. This strongly suggests that the ability to bind a pRb family member is required
in order for T-Ag to activate the human TK promoter.
Regulation of 135(E2F)-Luc in cells infected with Ad T/dl309
viruses. The results presented above indicate the importance
of a pRb family member in activation of the TK promoter by
T-Ag. One mechanism by which pRb family members exert
their antiproliferative effect is via binding to the E2F family of
transcription factors, resulting in repression of the transcriptional activity of these factors. This effect is abrogated in the
presence of DNA tumor virus proteins such as SV40 T-Ag and
adenovirus E1A. To determine the importance of the putative
E2F-binding sites in activation of the human TK promoter by
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FIG. 3. T-Ag protein, luciferase, and endogenous TK enzyme expression in 135-Luc cells infected with untreated (UT) and UV-irradiated (UV) viruses. Western
blots and TK assays were carried out as described in Materials and Methods. (A) Immunoblot of T-Ag protein in infected-cell extracts. For each colony (1, 3, 4, and
6), 25 mg of protein from 72-h extracts was analyzed. Ten microliters of an extract prepared from continuously cycling COS7 cells (SV40-transformed simian CV1 cells
which stably express T-Ag) was used as a marker for T-Ag. T-Ag was detected by using the monoclonal antibody Pab416. (B) Increase in luciferase expression at 72 h
for cells infected with untreated or UV-irradiated virus or for uninfected cells (72 un). (C) Increase in endogenous TK enzyme expression at 72 h after infection for
cells analyzed as in panel B. For both panels B and C, values reflect normalization to total protein content.

T-Ag, the regulation of 135(E2F)-Luc (Fig. 1), which contains
a mutation substituting nonhomologous sequences for the putative E2F-binding sites located between bp 298 and 2113,
was examined.
Six independent clonal cell lines containing 135(E2F)-Luc
were tested for their abilities to be activated by T-Ag. In addition, two 135-Luc cell lines were included to provide a wildtype promoter control in the same experiments. Cells were
infected with either untreated or UV-irradiated wild-type Ad
T/dl309 virus or were treated for 72 h with an equivalent
volume of a 293 cell lysate (mock infection). Average luciferase
induction levels are depicted in Fig. 8. Western blot analyses
were performed to confirm the presence of T-Ag in all experiments whose results are shown in Fig. 8 (data not shown). The
parental, unmutated 135-Luc constructs exhibited characteristic inductions of 11- to 14-fold with wild-type virus, and this
was decreased approximately 70% by UV irradiation. Luciferase expression in mock-infected cells was decreased to 40%
of the level attained with the UV-irradiated virus and was no

higher than that seen in untreated cells at 72 h. This suggests
that the induction seen with UV-irradiated virus was not due to
the presence of a 293 cell-derived factor(s) but was attributable
instead to virus-dependent, but T-Ag-independent, events.
Luciferase induction in five of the six 135(E2F)-Luc transfectants was severely diminished relative to that with the wildtype promoter. Specifically, induction levels with untreated
wild-type virus ranged from 1.5- to 4-fold. Moreover, luciferase
expression was not greatly decreased by UV irradiation of the
virus, indicating that the mutant TK promoters in these transfectants were not specifically activated by T-Ag. This is the
predicted result if the E2F-binding sites are required for activation by T-Ag. The pattern seen with the remaining colony,
1-2, is more puzzling. With the untreated Ad T/dl309 virus,
luciferase expression in colony 1-2 was induced to a level more
than twice that attained with the parental 135-Luc constructs.
In addition, expression in colony 1-2 cells infected with the
UV-irradiated virus was approximately one-third of that of the
untreated control. Expression in mock-infected and 72-h un-
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FIG. 5. SV40 T-Ag protein domains and mutations. Vertical bars on the map
represent every 100 amino acids. The exon I-exon II boundary at amino acids 82
and 83 is indicated by a vertical dashed line. Labeled brackets below the map
indicate domains of known function. T-Ag mutations analyzed in this study are
indicated above the diagram. in, insertion; dl, deletion; if, in-frame mutation.

infected extracts was not significantly higher than that at 0 h.
Thus, except for being overinduced, colony 1-2 exhibits a wildtype response to T-Ag. While we do not understand this result,
it may be due to position effects, such as integration next to a
T-Ag-responsive enhancer element. In any case, the fact that
five of the six mutant cell lines tested show severe defects in
activation by T-Ag suggests that the E2F-binding sites are
indeed important for activation.
Since both the pRb-binding domain of T-Ag and the putative E2F-binding sites within the TK promoter were required
for activation, a mechanism for the regulation of TK promoter

FIG. 4. Luciferase induction in HTK-Luc cells infected with untreated or
UV-irradiated virus. (A) Luciferase induction following infection with untreated
(UT) wild-type virus and in uninfected cells (72 un). Results are shown for four
independent clonal cell lines. For each sample, the number of experiments (n) is
as follows. Colony 1: UT, n 5 4; 72 un, n 5 2. Colony 8: UT, n 5 5; 72 un, n 5
4. Colony 9: UT, n 5 7; 72 un, n 5 6. Colony 10: UT, n 5 5; 72 un, n 5 6. (B)
Luciferase induction in cells infected with UV-irradiated (UV) or UT wild-type
virus and in uninfected cells. Results are shown for three independent colonies.
For all samples, n 5 2. Error bars reflect the standard error of the mean.

FIG. 6. T-Ag protein and luciferase induction levels in 135-Luc cells infected
with wild-type (WT) virus and viruses carrying C-terminal mutations (2809, 2911,
and 2827). Results are shown for three independent clonal cell lines. The 72-h
infected-cell extracts used for luciferase assays were also analyzed for T-Ag
expression by immunoblotting with a monoclonal antibody (L19) specific for the
N terminus of the T-Ag protein. For each sample, the corresponding immunoblot depicting T-Ag protein expression at 72 h after infection is shown below the
graph.
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FIG. 7. T-Ag protein and luciferase induction levels in 135-Luc cells infected
with wild-type (WT) and K1 mutant viruses. Results are shown for four clonal
cell lines, with two independent experiments shown for colony 1. The 72-h
infected-cell extracts were analyzed for T-Ag protein expression by immunoblotting with the monoclonal antibody Pab416. For each sample, the corresponding
immunoblot is shown below the graph.

J. VIROL.

activity involving an interaction between a pRb family member
and an E2F-like protein seemed likely. To further establish the
existence of such an interaction, the 135(E2F)-Luc cell lines
were infected with either untreated wild-type virus, untreated
K1 virus, or UV-irradiated K1 virus. If activation is due to an
interaction between a pRb family member and a protein binding to the E2F sites, the K1 virus should be no more defective
than the wild type in its ability to activate the promoter lacking
E2F-binding sites. If, however, the protein recognizing the E2F
sites does not associate with a pRb family member, the deficits
represented in the promoter and viral mutations should be
independent and additive, and infection of the 135(E2F)-Luc
transfectants with the K1 virus should result in induction levels
lower than those observed upon infection of either wild-type
promoter constructs with mutant virus or mutant promoter
constructs with wild-type virus. UV-irradiated K1 virus was
included for the purpose of assessing whether the T-Ag pRbbinding domain is the only T-Ag domain required for stimulation of the TK promoter; if the pRb-binding domain is the
only region involved, luciferase induction levels should be
equivalent with both untreated and UV-irradiated K1 virus
preparations. In contrast, if other domains of T-Ag are also
involved, UV irradiation of the K1 virus should result in further decreases in luciferase expression.
The results of these experiments are shown in Fig. 9. For all
experiments, the levels of T-Ag were equivalent in wild-type-

FIG. 8. Induction of luciferase by untreated (UT) and UV-irradiated (UV) wild-type virus in cells containing 135(E2F)-Luc. Results are shown for two clonal cell
lines carrying the wild-type 135-Luc hybrid gene and six clonal lines carrying the mutant 135(E2F)-Luc hybrid gene. Some cells were left uninfected and either
maintained in low-serum medium (72 un) or treated with a lysate from uninfected 293 cells (Mock). The viruses used are given directly below the graph, and the
identities of the colonies tested are listed below the viruses. High levels of T-Ag expression were confirmed in all experiments. The numbers of experiments (n) are
as follows. 135-Luc: UT, for both colonies n 5 6; mock, for both colonies n 5 4; 72 un, for both colonies n 5 4; UV, for colony 1 n 5 3 and for colony 3 n 5 4.
135(E2F)-Luc for colonies 1-2, 1-6, and 3-12: UT, n 5 6; UV, n 5 4; mock, n 5 4; 72 un, n 5 4. 135(E2F)-Luc for colonies 1-7, 3-2, and 3-5: UT, n 5 4; UV, n 5
2; mock, n 5 2; 72 un, n 5 2. Error bars reflect the standard error of the mean.
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FIG. 9. Induction of luciferase by wild-type (WT), K1, and UV-irradiated K1 (UV K1) viruses in cells containing 135(E2F)-Luc and in uninfected cells (72 un).
Viruses are given directly below the graph, and the identities of the colonies tested are listed below the viruses. High levels of T-Ag expression were confirmed in each
experiment by Western blotting. The numbers of experiments (n) are as follows. 135-Luc (both colonies): WT, n 5 6; K1, n 5 4, UV K1, n 5 2; 72 un, n 5 4.
135(E2F)-Luc (colony 1-6): WT, n 5 6; K1, n 5 4; UV K1, n 5 2; 72 un, n 5 4. 135(E2F)-Luc (colony 1-7): WT, n 5 4; K1, n 5 3; UV K1, n 5 2; 72 un, n 5 2.
135(E2F)-Luc (colony 3-2): WT, n 5 4; K1, n 5 4; UV K1, n 5 2; 72 un, n 5 2. 135(E2F)-Luc (colony 3-5): WT, n 5 4; K1, n 5 2; UV K1, n 5 2; 72 un, n 5 2.
135(E2F)-Luc (colony 3-12): WT, n 5 6; K1, n 5 4; UV K1, n 5 1; 72 un, n 5 4. Error bars reflect the standard error of the mean.

and K1-infected extracts (data not shown). As in previous
experiments, induction of 135-Luc colonies with the K1 virus
was reduced approximately 60% relative to the levels achieved
with the wild-type virus. Induction levels with UV-irradiated
K1 virus were decreased only slightly more, indicating that this
protein is almost completely defective for TK promoter activation. The 135(E2F)-Luc colonies exhibit the response predicted if T-Ag is activating the TK promoter by disrupting an
association between an Rb family member and E2F. Induction
levels with the K1 virus were at or near those produced with
the untreated wild-type virus and were not greatly decreased by
UV irradiation. These results are consistent with SV40 activating the TK promoter via the E2F sites, with the T-Ag pRbbinding domain being primarily responsible for this effect.
DISCUSSION
In this study, we have examined activation of a chromosomal
human TK promoter by SV40 T-Ag. This promoter is activated
during the infection of quiescent cells with SV40 and therefore
represents a true cellular target of T-Ag. Our results indicate
that a 135-bp TK promoter fragment was induced an average
of 10- to 15-fold in the presence of wild-type T-Ag protein.
Infections with UV-irradiated virus established that the majority of this induction (approximately 70%) was dependent upon
the expression of T-Ag and was specific to the human TK
promoter. Approximately 30% of the effect was T-Ag independent but virus dependent. This T-Ag-independent activation

was not promoter specific, since it occurred with the herpesvirus TK promoter and with a human TK promoter mutant
[135(E2F)] that no longer responds to T-Ag. The T-Ag-independent, nonspecific activation could be derived from several
sources. One possibility is signal transduction events triggered
by virus binding to cell surface receptors. Precedent for this is
found in the work of Zullo et al. (56), who detected increases
in c-myc and c-fos mRNA levels following exposure of cells to
either polyomavirus empty virions or recombinant VP1 protein. Alternatively, the induction seen with UV-irradiated virus
might be due to residual, yet undetectable, T-Ag expression.
We think it unlikely that this induction reflects the presence of
a 293 cell-derived factor in the virus preparations, since virtually no induction of the 135-Luc construct occurred in cells
mock infected with a 293 cell lysate (Fig. 8).
Using a series of adenoviruses expressing mutant forms of
T-Ag, we examined the activities of the protein that are required for efficient induction of the TK promoter. The mutants
examined included ones with mutations in the C-terminal helicase, ATPase, and p53-binding domains; in an N-terminal
region previously shown to be required for activation of the
SV40 late promoter in transient transfections; and in the pRb
family-binding domain. The only T-Ag mutant that was specifically defective in TK promoter activation was K1, which is
unable to bind pRb and related proteins. Luciferase induction
levels in K1-infected cells were 30 to 50% of wild-type levels
and just above that seen in cells infected with UV-irradiated
virus (Fig. 7 and 9). The finding that the pRb family-binding
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domain of T-Ag was required for TK promoter activation
suggested that the virus mediates its effect via the putative
E2F-binding sites within the promoter. To test this hypothesis,
we studied the expression of a hybrid gene construct [135
(E2F)-Luc] in which the E2F-binding sites were replaced with
nonhomologous sequences. Luciferase induction levels for five
of six 135(E2F)-Luc containing cell lines were severely decreased relative to that for unmutated controls and were near
the background level defined by UV irradiation experiments.
The remaining 135(E2F)-Luc transfectant displayed a wildtype phenotype, which we propose may be due to integration of
the transfected gene in the vicinity of a strong enhancer or
regulatory element that responds to T-Ag.
The fact that both T-Ag mutants defective for binding to
pRb family members and TK promoter mutants with alterations in sequences resembling E2F-binding sites are defective
for TK promoter activation leads us to conclude that T-Ag is
activating this promoter via its interactions with the pRb family
of proteins. Since the activation of other promoters, such as the
SV40 late promoter and the Rous sarcoma virus long terminal
repeat, are independent of this function (54), we propose that
the specific activation of proliferation-dependent genes during
viral infection and the activation of many promoters by T-Ag in
transient-cotransfection assays occur by different mechanisms.
The pRb-dependent mode of activation appears to be selective
for growth-regulated, natural targets of T-Ag such as TK. A
more general, pRb-independent mechanism appears to account for the promiscuous activation of both viral and cellular
promoters that is observed in transient-cotransfection assays.
This second mechanism may function only on genes in an
episomal state and is likely to be responsible for the activation
of the SV40 late promoter during viral infection. That T-Ag
might utilize several different mechanisms to activate transcription is not surprising, given the numerous activities of this
protein, including the ability to bind DNA (6), the ability to
bind to elements of the cellular transcription apparatus such as
TBP and TEF-1 (2, 23, 28), and the ability to bind to cellular
regulatory molecules such as p53 (36) and the pRb family of
proteins (12, 16).
Several interesting questions are raised by these studies. The
first is whether the pRb family-binding domain is the only T-Ag
domain required for TK promoter activation. As shown in Fig.
9, UV irradiation of the K1 virus lowers luciferase induction
slightly, suggesting that this T-Ag is not completely defective.
There are several possible explanations for this finding. First,
the K1 mutation may not totally abolish interactions between
T-Ag and pRb family members (55). Alternatively, other T-Ag
domains, such as the TBP- or TEF-1-binding domains, may be
conferring part of the activity. We attempted to investigate
whether the T-Ag domains that are required for the activation
of simple promoters are also required for TK promoter activation by examining mutants (inA2803 and dlA2831) that are
defective in this general trans-activation function. Unfortunately, the proteins encoded by these mutants were unstable in
rat cells, and we were therefore unable to determine their
effect on TK promoter activation. Finally, some activity might
be contributed by SV40 small t antigen (t-Ag). t-Ag has been
reported to activate some promoters and may therefore have
some activity in our system (38). It may also be contributing to
TK promoter activation indirectly, since it has been shown to
stimulate cell proliferation by inhibiting the actions of regulatory phosphatases such PP2A (48, 51). t-Ag does not play a
major role in TK promoter activation, however, since the K1
mutant, which encodes a wild-type t-Ag, is almost completely
defective.
A second interesting issue is raised by our finding that the

J. VIROL.

E2F sites in the TK promoter were required for T-Ag-mediated activation. This was somewhat surprising, since we previously demonstrated that a human TK promoter fragment from
bp 267 to 130, which lacks the putative E2F-binding sites, was
activated in CV1 cells following SV40 infection (44). We therefore reexamined our previous finding by constructing a hybrid
gene (67-Luc) containing the TK promoter fragment from bp
267 to 130, stably transfecting it into Rat-1 cells, and infecting
with Ad T/dl309. 67-Luc was modestly induced (two- to fourfold) in this system, but the induction was not dependent on
T-Ag, as determined by UV irradiation experiments (1a). Since
our earlier experiments with CV1 cells did not employ UVirradiated virus, it is likely that the induction detected was due
to T-Ag-independent effects, such as binding of virus to the cell
surface. It is also possible that the levels of T-Ag were higher
in the infected CV1 cells, since SV40 replicates in that system.
A final issue is the identity of the cellular proteins involved
in TK promoter activation. Gel shift analyses have detected
constitutive binding of the p33cdk2 protein kinase, and G1/Sphase-specific binding of a complex dependent upon cyclin A
and p107, to the human TK promoter (37). Interestingly, pRb
was not detected as a component of any of the complexes
formed, suggesting that it may be the ability of T-Ag to bind
p107, rather than pRb, which is involved in TK trans activation.
In addition, both an E2F antiserum and an oligomer containing a single E2F consensus site were ineffective at altering the
formation of any of the detected complexes, suggesting that
E2F-1, at least, is not the protein binding these sites. Since
there are at least five members of the E2F transcription factor
family, including two which interact specifically with p107
and/or p130 rather than pRb (17, 21, 26), the protein involved
in human TK promoter regulation may be one of these related
forms. Determination of the specific proteins involved will be
the focus of future studies.
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